We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Delays Decision On Roche Anemia Drug

Law360 (December 15, 2006, 12:00 AM EST) -- U.S. regulators have accepted Roche Holding AG’s Biologic License Application for its hotly litigated anti-anemia drug Mircera, but will extend their review for another three months to review extra data submitted...
To view the full article, register now.